Edesa Biotech holds 2022 annual meeting; all director nominees elected, say-on-pay approved

Edesa Biotech, Inc.

Annual meeting held May 18, 2022; 6,975,601 shares (50.1%) represented.
All seven director nominees elected: Chao, Johnson, MacDonald, Nijhawan, Oakes, Pay, Sistilli.
Advisory vote on executive compensation approved: 4,105,670 for, 373,029 against.
Frequency vote chose 'every year' (4,213,160 votes); company will hold annual say-on-pay.
MNP LLP appointed as independent auditor for 2023 with 6,860,304 votes in favor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.